Cross-Sector entity
The clearest coverage concentration is markets: 5 of 8 stories, with the rest divided among 3 other categories. Of the tracked stories, 3 of 8 also mention Geode Capital Management LLC, the most common co-covered peer. Across a 176-day span, the pace is roughly 0.3 stories per week. The busiest single day carried 2.
8 verified stories tracked
Last mentioned: Aug 17, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
The clearest coverage concentration is markets: 5 of 8 stories, with the rest divided among 3 other categories. Of the tracked stories, 3 of 8 also mention Geode Capital Management LLC, the most common co-covered peer. Across a 176-day span, the pace is roughly 0.3 stories per week. The busiest single day carried 2. 0% of these stories carry negative sentiment. Vanguard Group Inc. appears in 8 tracked Cross-Sector stories published from February 23, 2026 through August 17, 2026. The tracked stories average 2.6 original sources each.
Computed from the 8 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Vanguard Group Inc.. Shared-story counts are live from our verified record — not editorial picks.
13F disclosures reported
Multiple outlets reported the SEC Form 13F filings, including that Zoetis shares opened at $73.64 on Friday.
Q2 2026 Earnings Release
Company reported EPS of ($0.19), missing consensus by $0.03.
Ladenburg Thalmann Upgrade
Ladenburg Thalmann upgraded CRVS to ‘strong-buy’.
Weiss Ratings Upgrade
Weiss Ratings upgraded Corvus from ‘sell (e+)’ to ‘sell (d-)’.
Q2 2026 United Super reductions
United Super cut Nebius by 20.5%, selling 3,390 shares to hold 13,147, and reduced Zoetis by 95.6%, selling 251,749 shares to hold 11,600.
Director Insider Purchase
Director David Scott Moore acquired 21,700 shares at $11.53 per share, totaling $250,201.
Wall Street Zen Downgrade
Wall Street Zen downgraded CRVS from ‘hold’ to ‘sell’.
Insider share sale
Senior Vice President Brian Daniel Alexander sells 37,860 shares at an average price of $59.97, totaling $2.27 million, reducing his direct ownership to 44,229 shares.
Goldman Sachs Initiates Coverage
Goldman Sachs issued a ‘buy’ rating and a $40.00 target price for Corvus Pharmaceuticals.
Polianta Ltd enters the stock
Polianta Ltd establishes a new 30,000-share position valued at $1.596 million, as disclosed in its 13F filing for the first quarter.
Q1 2026 Nebius position increases
Amundi lifted Nebius by 10.6% to 1,343,954 shares worth $139,449,000; Lombard Odier, HB Wealth Management, Wealth Alliance, Empirical Financial Services, and Aspen Grove Capital also added or initiated Nebius positions.
Heavy institutional accumulation intensifies
Vanguard Group increases its holding by 47.6% to 6.93 million shares; M&T Bank Corp posts a 1,108.8% surge to 330,882 shares; Handelsbanken Fonder adds 54.3% to reach 423,020 shares; Parkside Financial doubles to 536 shares; and Wealthfront Advisers initiates a new position worth $1.58 million.
Institutional buying wave begins
ARK Investment Management increases its stake by 32.4% to 589,887 shares. MAI Capital Management boosts its position by 833.3% to 560 shares, and Ameriflex Group lifts holdings by 1,500% to 704 shares.
The State of Wyoming disclosed new Q2 2026 13F positions in Cardinal Health ($921K) and Builders FirstSource ($828K), but the larger signal is institutional accumulation: CAH is 87.17% institutionally owned with Vanguard and Norges adding, while BLDR is 95.53% owned despite a Q2 earnings miss.
Source: dailypolitical.com · tickerreport.com
United Super, in its capacity as trustee for the Construction & Building Unions Superannuation Fund, cut its Nebius stake by 20.5% to $3.63 million and nearly exited Zoetis, reducing that position by 95.6% to $834,000 in Q2 2026. The 13F reveals rotation away from animal health while retaining AI-infrastructure exposure.
Source: Ticker Report · Daily Political
Corvus Pharmaceuticals missed Q2 EPS by $0.03, highlighting the financial fragility of early-stage oncology R&D. With no near-term data readouts, the miss draws attention to cash burn and the critical need for clinical progress to justify its $1.17B valuation.
Source: dailypolitical.com · tickerreport.com
CoreWeave, a vital GPU cloud provider for AI workloads, saw its stock plunge 48% from its high as a top insider sold $19M in shares. With revenue surging 111.6% but the company deeply leveraged at 3.68 D/E, the AI infrastructure boom faces a reality check.
Brannin Mcbee, a top CoreWeave insider, sold $19M worth of shares across two days under a 10b5-1 plan, reducing his stake by a combined 50.67% as the stock sits 48% below its peak. The sales highlight the delicate dance of founder and executive liquidity in the AI infrastructure startup space.
A wave of institutional buying is hitting Symbotic even as the stock sits 53% below its peak, with Polianta Ltd initiating a new $1.6 million position and Vanguard boosting its stake by 47.6% to $412 million. The divergence between insider selling and fund accumulation sets up a high-stakes test for investors. With a negative PE and a beta near 2, the stock remains a volatile but potentially rewarding play on warehouse automation.
Source: Bbns · The Lincolnian Online
Creek Drive Management Group initiates a $1.4 million position in EVLV, as institutional ownership reaches 66.65%. Large funds like Vanguard and State Street add to positions, and an analyst target of $10 highlights upside potential for the AI security firm.
Source: themarketsdaily.com · zolmax.com
Vanguard Group Inc. increased its position in Blue Owl Capital Inc. (OWL) by 7.9% during the third quarter, acquiring nearly 5 million additional shares. This move brings Vanguard's total holdings to approximately 67.9 million shares, signaling strong institutional confidence in the alternative asset management sector.
Source: Watch List News · Ticker Report
